Menu
Search
|

Menu

Close
X

Hubei Biocause Pharmaceutical Co Ltd 000627.SZ (Shenzhen Stock Exchange)

6.15 CNY
-0.07 (-1.13%)
As of 3:30 AM BST
Previous Close 6.22
Open 6.19
Volume 3,131,400
3m Avg Volume 18,512,907
Today’s High 6.20
Today’s Low 6.14
52 Week High 8.05
52 Week Low 4.88
Shares Outstanding (mil) 4,940.63
Market Capitalization (mil) 30,829.53
Forward P/E 23.40
Dividend (Yield %) -- ( 0.48 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, CNY)
FY19
22,676
FY18
30,952
FY17
53,407
FY16
16,993
EPS (CNY)
FY19
0.067
FY18
0.268
FY17
0.296
FY16
0.421
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
23.40
22.18
Price to Sales (TTM)
vs sector
0.81
10.42
Price to Book (MRQ)
vs sector
1.52
3.25
Price to Cash Flow (TTM)
vs sector
--
19.62
Total Debt to Equity (MRQ)
vs sector
0.55
55.59
LT Debt to Equity (MRQ)
vs sector
0.55
30.20
Return on Investment (TTM)
vs sector
--
0.33
Return on Equity (TTM)
vs sector
6.67
16.32

EXECUTIVE LEADERSHIP

Yiqian Liu
Chairman of the Board, Since 2015
Salary: --
Bonus: --
Dali Chen
Vice Chairman of the Board, Since 2013
Salary: --
Bonus: --
Tinghao Yi
Chief Financial Officer, Director, Since
Salary: --
Bonus: --
Yunhua Xiao
General Manager, Director, Since
Salary: --
Bonus: --
Bin Liu
Deputy General Manager, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Financials
Industry: Life & Health Insurance
Address:

No. 132, Yangwan Road
JINGMEN   HUB   448000

Phone: +86724.2223218

Hubei Biocause Pharmaceutical Co.,Ltd. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The Company is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The Company distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.

SPONSORED STORIES